Wird geladen...
Explanations for the high potency of HPV prophylactic vaccines
HPV L1 virus-like particle (VLP) vaccines administered in a prime/boost series of three injections over six months have demonstrated remarkable prophylactic efficacy in clinical trials and effectiveness in national immunization programs with high rates of coverage. There is mounting evidence that th...
Gespeichert in:
| Veröffentlicht in: | Vaccine |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Elsevier Science
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6035892/ https://ncbi.nlm.nih.gov/pubmed/29325819 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2017.12.079 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|